Back |
home / stock / mnkd / mnkd message board
Subject | By | Source | When |
---|---|---|---|
Both shallow: MNKD has life again. Earnings number today after close ************ | Both shallow | investorshangout | 05/10/2017 6:51:18 PM |
ultimateshort: This thing is dead. I don't believe anything will cure it for foreseeable future. | ultimateshort | investorshangout | 02/13/2017 6:12:24 PM |
mc67: $MNKD Has No Balls.. they let outside criminals kill this company w/out a FIGHT ... what a bun | mc67 | investorshangout | 02/02/2017 1:19:41 PM |
mc67: $MNKD : Using Afrezza Is practicing preventive medicine !! www.caremark.com/portal/asset/hsp p | mc67 | investorshangout | 02/01/2017 5:53:09 PM |
mc67: $MNKD The following is excerpted from Issue #264 of Nates Notes, All-in on MannKind (MNKD) 1/2 | mc67 | investorshangout | 01/28/2017 10:52:57 AM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 10:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Study proves inhaled insulin is as effective as usual care (primarily automated insulin delivery pumps or multiple daily injections) for adults living with T1D meeting the primary endpoint Patients utilizing inhaled insulin reached target A1c (less than 7%) 30% of the time compared to 17%...
17-week endpoint results comparing Afrezza ® head-to-head with multiple daily injections (MDI) and insulin pumps INHALE-3 Study Protocol Chair Dr. Irl. B. Hirsh joined by investigational team to deliver presentation moderated by Jaeb Center founder Dr. Roy W. Beck ...